Skip to main content
Smart Investors Daily
Merck KGaA logo

OTC · MKKGY

Merck KGaA

Healthcare · Drug Manufacturers - Specialty & Generic

$32.19

Down-$0.32 (-0.98%)

Updated Nov 20, 2026, 3:39 PM

SID Score

8.2/10

Composite research score

Smart Money

46/100

Neutral

Market cap
61.14B
P/E ratio
17.39
Dividend yield
1.55%
52-week range
$23.73 – $34.19
Volume
51.2K
Avg. volume
155.75K

Price performance · MKKGY

MKKGY price history

1M range · 1 trading sessions · Daily adjusted prices

Prices through Oct 22, 2026

MKKGY closed at $32.91 after 1 trading sessions, up 0.00% for the selected period.

No results

At least two price observations are needed to draw this chart.

Latest MKKGY news

The latest Smart Investors Daily articles mentioning MKKGY.

MKKGY research

Overview

Company profile and research snapshot.

Company profile

MERCK KGAA SPNS/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$53.96
Implied upside
—
Analysts
10
MKKGY recent ratings
DateFirmRatingTarget
Sep 23, 2026ROTHSCHILD & CO REDBURNBuy—
Sep 21, 2026DAY BY DAYHold—
Sep 10, 2026BAADER EUROPE / ALPHAVALUEBuy—
Sep 4, 2026EQUITA SIMHold—
Sep 3, 2026JEFFERIESHold—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 12, 2026

Merck KGaA (MKKGY) Lags Q3 Earnings Estimates

Merck KGaA (MKKGY) delivered earnings and revenue surprises of -52.00% and +5.32%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Yahoo · Nov 12, 2026

Merck KGaA Q3 profit slumps 50%; hikes annual guidance

Investing.com-- Merck KGaA (ETR:MRCG) clocked a sharp drop in its third-quarter earnings on Thursday, but raised its annual guidance on expectations of more demand for chip materials and drugmaking products.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.